Synmosa Biopharma CorpTPEX: 4114

Synmosa Biopharma To announces SYNMOSA board of directors has lifted the restriction on the prohibition of competition for managerial officer

· Issued by Synmosa Biopharma Corp
Close
Today's Information

Provided by: SYNMOSA BIOPHARMA CORPORATION
SEQ_NO 1 Date of announcement 2022/08/11 Time of announcement 15:54:09
Subject
 To announces SYNMOSA board of directors has
lifted the restriction on the prohibition of
competition for managerial officer
Date of events 2022/08/11 To which item it meets paragraph 21
Statement
1.Date of the board of directors resolution:2022/08/11
2.Name and title of the managerial officer with
permission to engage in competitive conduct:
Lin, Chih-Hui/General Manager
3.Items of competitive conduct in which the officer is
permitted to engage:
Serving as a managerial officer、director or supervisor of a company with
the same or similar business scope as the company.
4.Period of permission to engage in the competitive
conduct:
Managerial officer while working as a supervisor of the company.
5.Circumstances of the resolution (please describe the
results of voting in accordance with Article 32 of the
Company Act):
All directors passed without objection.
6.If the permitted competitive conduct belongs to the
operator of a mainland China enterprise, the name and
 title of the managerial officer (if it is not the
operator of a mainland China enterprise, please enter
"N/A" below):N/A
7.Company name of the mainland China enterprise and the
officer's position in the enterprise:N/A
8.Address of the mainland China enterprise:N/A
9.Operations of the mainland China enterprise:N/A
10.Impact on the company's finance and business:none
11.If the managerial officer or director has invested in
 the mainland China enterprise, the monetary amount of the
 investment and the officer or director's shareholding ratio:none
12.Any other matters that need to be specified:none

Company analysis

Earlier from Synmosa Biopharma

All Synmosa Biopharma news releases